.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India currently faces a significant surge in metabolic health risks, with over one-third of the population showing early clinical markers for chronic diseases. A recent report titled \"India's Silent Health Crisis\" by ekincare analyzed over four lakh health check-ups conducted between 2023 and 2025. Consequently, the data highlights an invisible crisis affecting individuals who appear healthy but harbor underlying pathology. This metabolic shift suggests that India is heading toward a lifestyle disease epidemic that requires urgent clinical attention.
The report reveals that more than 36% of Indians suffer from vitamin deficiencies, indicating massive nutritional gaps. Additionally, nearly one in three individuals shows obesity markers, while 31.7% present with abnormal cholesterol levels. Therefore, these individuals face an elevated cardiovascular risk long before symptoms manifest. Furthermore, almost 30% of the population is at risk for diabetes based on HbA1c and fasting blood sugar levels. Early screening remains the most effective tool to mitigate these metabolic health risks before they progress to end-organ damage.
Regional data shows significant disparities in health outcomes across the country. For instance, Andhra Pradesh recorded a diabetes risk of 56.9%, which is nearly double the national average. Meanwhile, Haryana and Karnataka reported the highest cardiovascular risks at 34.9% and 33.7% respectively. Beyond heart and sugar levels, 16.4% of the population suffers from iron deficiency. Moreover, abnormal readings in liver, thyroid, and kidney markers suggest increasing organ stress. These findings underscore the necessity for localized healthcare interventions and regular monitoring.
Q1: Which Indian states show the highest risk for diabetes?
According to the ekincare report, Andhra Pradesh has the highest risk at 56.9%, followed by Odisha at 42.5%.
Q2: What are the primary markers used to identify metabolic risk in this study?
The study utilized indicators such as cholesterol levels, HbA1c, fasting blood sugar, and BMI to identify early markers of heart disease, diabetes, and obesity.
Q3: How widespread is vitamin deficiency in India?
Over 36% of the population is vitamin deficient, with Rajasthan reporting the highest severity at 43.9%.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A report by ekincare reveals that over 36% of Indians show early signs of metabolic disorders, including heart disease and diabetes, before symptoms appear....
5 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
